The following outcome data were collected: use of prone positioning, need for extracorporeal membrane oxygenation (ECMO) support, duration of invasive mechanical ventilation (IMV) and ECMO (if applicable), ICU length of stay (ICU-LOS) and ICU mortality.
Duration of mechanical ventilation, duration of vasopressor support, duration of ICU and hospital stays, the incidences of new infection, incidence of ARDS, 28-day mortality and overall mortality were also recorded.
We collected information on stroke type and location, time to intubation, reason for intubation, length of ventilatory support, duration of ICU stay.
Linear regression analysis was conducted to control for the effect of education, household income, sociodemographic characteristics, lifestyle-related behaviors, social support, duration of disease, insulin treatment, complications, and health care access problems.
Furthermore, there were no statistically significant differences in the duration of ventilatory support, duration of oxygen supply, or age of weaning from respiratory support (defined as assisted ventilation or oxygen supplementation) between the two treatment groups [ 53].
There was no association between TGFβ mRNA copy numbers and outcome measures such as mortality, the presence of shock after prolonged sepsis, duration of vasopressor support, duration of mechanical ventilation and duration of intensive care stay.
